Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05665179 · ClinicalTrials.gov registry record · NA
Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis
A NA study of Opioid Use Disorder and Alcohol Use Disorder, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 2
- Study locations
NCT05665179: Recruiting NA study of Opioid Use Disorder and Alcohol Use Disorder, sponsored by University of Michigan.
NCT05665179 is a NA study of Opioid Use Disorder and Alcohol Use Disorder that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 800 participants, below the 4,653-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05665179, a NA study of Opioid Use Disorder and Alcohol Use Disorder, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 2
- Study locations
Study Summary
The opioid epidemic has become one of America's deadliest crises, surpassing car crashes, firearms, and HIV/AIDS as a leading cause of death for Americans under fifty years of age. People trying to recover from opioid-use disorder face many obstacles. Obstacles such as minor legal problems (e.g., arrest warrants for failure to pay a fine, failure to appear in court, or late child support payments) can undermine the stability needed to overcome opioid dependence. Outstanding legal obligations make it difficult to find jobs and to secure housing. They can result in removal from treatment programs as well as incarceration. Resolving these legal problems requires coordination, organization, preparation, travel, and time-expectations that may be problematic for many people in the early stages of recovery. Technology has the potential to make resolving these legal problems much easier. Online platform technology is now available that can guide people in recovery through the resolution of many legal problems at no cost and without an attorney, potentially doing so quickly, remotely, and at any time of day. This study of individuals in treatment in Michigan tests whether resolving outstanding legal issues improves drug treatment outcomes. The research also examines whether and to what extent resolving legal issues supports family reunification, reduces future criminal behavior, and improves access to jobs and housing for clients in treatment for opioid use disorder. A randomized controlled trial (RCT) is used to determine the effects of resolving legal issues on these outcomes. For identification, the investigators leverage the random assignment of legal services to treatment center clients, along with the random assignment of clients to treatment centers by birth month. We assemble a novel longitudinal dataset of hundreds of clients in treatment for substance use disorder and link these clients to several administrative datasets and qualitative data, which allows for meas
Primary Outcome
Consulting electronic medical records, we measure how frequently the participant report using substance(s). Daily rates will be recorded or calculated if frequency of use is recorded in weekly, monthly, or annual terms.
Conditions Studied
Interventions
- BEHAVIORAL Removing Barriers to Recovery
Study Locations (2)
Michigan
- Home of New Vision - Ann Arbor
- Dawn Farm - Ypsilanti
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2021-12-23 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What NCT05665179 shows while recruiting
NCT05665179 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 4,653-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (83% lower).
The record links to 6 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Removing Barriers to Recovery is the first listed.
NCT05665179 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05665179 about?
NCT05665179 is a clinical study titled "Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis". The opioid epidemic has become one of America's deadliest crises, surpassing car crashes, firearms, and HIV/AIDS as a leading cause of death for Americans under fifty years of age. People trying to recover from opioid-use disorder face many obstacles. Obstacles such as minor legal problems (e.g., ar...
What is the current status of trial NCT05665179?
This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2021-12-23. Estimated completion is 2025-07-31.
What conditions does trial NCT05665179 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Alcohol Use Disorder, Criminal Behavior, Housing Problems, Health Risk Behaviors.
What interventions are being tested in trial NCT05665179?
The interventions under investigation include: Removing Barriers to Recovery (BEHAVIORAL).
Who is sponsoring clinical trial NCT05665179?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05665179 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05665179's enrollment target sits among peer trials
800 23rd of 257 higher than 235 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI